DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
G••••• H•••••
H•••••care & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
What matters now
- $1.91Mprincipal outstanding
$1.91M principal held by 1 lender; matures Jul 2028.
Q2 2026 · Refinancing is due in 21 months at a 98¢ mark.
FactBDC schedules of investments, 30 Jun 2026; a sum of the BDCs' pieces, a lower bound
Mark path, consensus per quarter end
98¢ · 98¢ · 98¢ · 98¢ · 98¢Q2 2025 to Q2 2026
Principal held
at least $1.9M
sum of BDC pieces, a lower bound
Fair value
$1.9M
98c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Jul 3, 2028
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Jun 30, 2026
Events
0
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| A•••• C••••• B•• I••• | $1.91M | 98¢ | 0 pts |
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••• C••••• B•• I••• | term loan first lien Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 4.50% I••••••• R••• 8.23% A••••••••• D• | $1.9M | $1.9M 98c | SOFR+450 bp |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $1.9M | 98c | SOFR+450 bp | Jul 3, 2028 | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $1.9M | $1.9M | 98c | 0 |
| Mar 31, 2026 | 1 | $1.9M | $1.9M | 98c | 0 |
| Dec 31, 2025 | 1 | $1.9M | $1.9M | 98c | 0 |
| Sep 30, 2025 | 1 | $1.9M | $1.9M | 98c | 0 |
All 14 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2025 | 1 | $1.9M | $1.9M | 98c | 0 |
| Mar 31, 2025 | 1 | $1.9M | $1.9M | 98c | 0 |
| Dec 31, 2024 | 1 | $3.9M | $3.8M | 98c | 0 |
| Sep 30, 2024 | 1 | $1.9M | $1.9M | 98c | 0 |
| Jun 30, 2024 | 1 | $1.9M | $1.9M | 97c | 0 |
| Mar 31, 2024 | 1 | $2.0M | $1.9M | 98c | 0 |
| Dec 31, 2023 | 1 | $3.9M | $3.8M | 98c | 0 |
| Sep 30, 2023 | 1 | $2.0M | $1.9M | 98c | 0 |
| Jun 30, 2023 | 1 | $2.0M | $1.9M | 98c | 0 |
| Dec 31, 2022 | 1 | $2.0M | $1.9M | 98c | 0 |
What changed
No non-routine event yet: the borrower has been held without a facility-level change since it appeared.
Every change including routine onesSponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- G••••• H•••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- H•••••care & Pharmaceuticalsreportedas one filer wrote it